Cargill   Report issue

For profit Phase 3
Founded: Minnetonka MN United States (1865)
Status: No NME R&D (1865)

Organization Overview

First Clinical Trial
2004
NCT00153738
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Cargill | Cargill FIS/ Global Food Research | Cargill R&D Centre Europe, Havenstraat 84, 1800 Vilvoorde, Belgium

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 15
  • # of Trial APIs: 18